Brokerages Set $11.00 Target Price for Crawford & Company (CRD.B)

Crawford & Company (NYSE:CRD.B) has been assigned an average broker rating score of 1.33 (Strong Buy) from the three analysts that cover the stock, Zacks Investment Research reports. One research analyst has rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company.

Analysts have set a 12 month consensus price target of $11.00 for the company and are predicting that the company will post $0.16 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Crawford & Company an industry rank of 203 out of 255 based on the ratings given to related companies.

Separately, Zacks Investment Research upgraded shares of Crawford & Company from a “sell” rating to a “hold” rating in a research report on Tuesday, December 4th.

Shares of NYSE CRD.B opened at $9.13 on Friday. Crawford & Company has a 1-year low of $7.54 and a 1-year high of $10.56. The stock has a market capitalization of $516.32 million, a price-to-earnings ratio of 11.56 and a beta of 1.00. The company has a quick ratio of 1.42, a current ratio of 1.42 and a debt-to-equity ratio of 0.95.

The firm also recently declared a quarterly dividend, which was paid on Thursday, March 14th. Stockholders of record on Thursday, February 28th were given a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 2.19%. The ex-dividend date of this dividend was Wednesday, February 27th. Crawford & Company’s dividend payout ratio is 25.32%.

About Crawford & Company

Crawford & Company provides claims management solutions to insurance companies and self-insured entities worldwide. The company operates through four segments: U.S. Services, International, Broadspire, and Garden City Group. It offers Crawford Solution, which provides integrated claim, business process outsourcing, and consulting services for various product lines, such as property and casualty claims management, workers' compensation claims and medical management, and legal settlement administration.

Read More: How is net asset value different from market price?

Get a free copy of the Zacks research report on Crawford & Company (CRD.B)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Crawford & Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crawford & Company and related companies with's FREE daily email newsletter.